Epidemiologic and clinical characteristics of infective endocarditis: a single-center retrospective study in the Bronx, New York.
Adult
Endocarditis
/ epidemiology
Endocarditis, Bacterial
/ microbiology
Female
Hospital Mortality
Humans
Methicillin-Resistant Staphylococcus aureus
Middle Aged
New York
/ epidemiology
Retrospective Studies
Staphylococcal Infections
/ microbiology
Staphylococcus aureus
Substance Abuse, Intravenous
/ microbiology
Bronx
Epidemiology
Infective endocarditis
New York
Observational study
Staphylococcus aureus
Journal
Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
24
11
2021
accepted:
01
05
2022
pubmed:
26
5
2022
medline:
4
10
2022
entrez:
25
5
2022
Statut:
ppublish
Résumé
There is paucity of data on the epidemiological, microbiological, and clinical characteristics of patients admitted with infective endocarditis (IE) in the Bronx, New York. We conducted a retrospective study at Jacobi Medical Center, a tertiary care hospital in the Bronx. All adult patients who were hospitalized with a primary diagnosis of new-onset IE between January 1st, 2010 and September 30th, 2020 were included. The primary outcome was in-hospital mortality. A logistic regression model was used to identify baseline variables associated with in-hospital mortality. 182 patients were included in this analysis (female sex: 38.5%, median age: 54 years). 46 patients (25.3%) reported intravenous drug use. 153 patients (84.1%) had positive blood cultures. Staphylococcus aureus (S. aureus) was the most common isolated pathogen (45.1% of monomicrobial IE). Nearly half of the cases secondary to S. aureus were methicillin resistant Staphylococcus aureus (MRSA) (34/69). 164 patients (90.1%) were diagnosed with native valve IE. The mitral valve was involved in 32.4% of patients followed by the aortic valve (19.8%). The in-hospital mortality was 18.1%. The mortality was higher in the cohort 2010-2015 compared to the cohort 2016-2020 (22.1% vs 14.6%). Increasing age, MRSA IE, and active malignancy were the only variables found to have significant association with in-hospital death. S. aureus was the most common causative agent and MRSA accounted for about half of the S. aureus IE cases. The incidence of IE in patients with intravenous drug use increased over time, while the median age decreased. The in-hospital death rate was higher in 2010-2015 compared to 2016-2020.
Identifiants
pubmed: 35614176
doi: 10.1007/s15010-022-01846-3
pii: 10.1007/s15010-022-01846-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1349-1361Commentaires et corrections
Type : CommentIn
Type : ErratumIn
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Références
Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016;387:882–93.
pubmed: 26341945
doi: 10.1016/S0140-6736(15)00067-7
Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, Karchmer AW, Olaison L, Pappas PA, Moreillon P, Chambers ST, Chu VH, Falcó V, Holland DJ, Jones P, Klein JL, Raymond NJ, Read KM, Tripodi MF, Utili R, Wang A, Woods CW, Cabell CH. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the international collaboration on endocarditis-prospective cohort study. Arch Intern Med. 2009;169:463–73.
pubmed: 19273776
pmcid: 3625651
doi: 10.1001/archinternmed.2008.603
Holland TL, Baddour LM, Bayer AS, Hoen B, Miro JM, Fowler VG Jr. Infective endocarditis. Nat Rev Dis Primers. 2016;2:16059.
pubmed: 27582414
pmcid: 5240923
doi: 10.1038/nrdp.2016.59
Mostaghim AS, Lo HYA, Khardori N. A retrospective epidemiologic study to define risk factors, microbiology, and clinical outcomes of infective endocarditis in a large tertiary-care teaching hospital. SAGE Open Med. 2017;5:2050312117741772.
pubmed: 29163950
pmcid: 5692128
doi: 10.1177/2050312117741772
Bin Abdulhak AA, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA, Tleyjeh IM. Global and regional burden of infective endocarditis, 1990–2010: a systematic review of the literature. Glob Heart. 2014;9:131–43.
pubmed: 25432123
doi: 10.1016/j.gheart.2014.01.002
Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, Hirsch GA, Mehta JL. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65:2070–6.
pubmed: 25975469
doi: 10.1016/j.jacc.2015.03.518
Ternhag A, Cederström A, Törner A, Westling K. A nationwide cohort study of mortality risk and long-term prognosis in infective endocarditis in Sweden. PLoS One. 2013;8: e67519.
pubmed: 23861768
pmcid: 3704638
doi: 10.1371/journal.pone.0067519
Keller K, von Bardeleben RS, Ostad MA, Hobohm L, Munzel T, Konstantinides S, Lankeit M. Temporal trends in the prevalence of infective endocarditis in Germany between 2005 and 2014. Am J Cardiol. 2017;119:317–22.
pubmed: 27816113
doi: 10.1016/j.amjcard.2016.09.035
Selton-Suty C, Célard M, Le Moing V, Doco-Lecompte T, Chirouze C, Iung B, Strady C, Revest M, Vandenesch F, Bouvet A, Delahaye F, Alla F, Duval X, Hoen B. Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis. 2012;54:1230–9.
pubmed: 22492317
doi: 10.1093/cid/cis199
Ahtela E, Oksi J, Vahlberg T, Sipilä J, Rautava P, Kytö V. Short- and long-term outcomes of infective endocarditis admission in adults: a population-based registry study in Finland. PLoS One. 2021;16: e0254553.
pubmed: 34265019
pmcid: 8282023
doi: 10.1371/journal.pone.0254553
Cresti A, Chiavarelli M, Scalese M, Nencioni C, Valentini S, Guerrini F, D’Aiello I, Picchi A, De Sensi F, Habib G. Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther. 2017;7:27–35.
pubmed: 28164010
pmcid: 5253443
doi: 10.21037/cdt.2016.08.09
Vogkou CT, Vlachogiannis NI, Palaiodimos L, Kousoulis AA. The causative agents in infective endocarditis: a systematic review comprising 33,214 cases. Eur J Clin Microbiol Infect Dis. 2016;35:1227–45.
pubmed: 27170145
doi: 10.1007/s10096-016-2660-6
Cahill TJ, Baddour LM, Habib G, Hoen B, Salaun E, Pettersson GB, Schäfers HJ, Prendergast BD. Challenges in infective endocarditis. J Am Coll Cardiol. 2017;69:325–44.
pubmed: 28104075
doi: 10.1016/j.jacc.2016.10.066
Greenspon AJ, Patel JD, Lau E, Ochoa JA, Frisch DR, Ho RT, Pavri BB, Kurtz SM. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011;58:1001–6.
pubmed: 21867833
doi: 10.1016/j.jacc.2011.04.033
Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J Am Coll Cardiol. 2006;48:590–1.
pubmed: 16875991
doi: 10.1016/j.jacc.2006.05.016
Slipczuk L, Codolosa JN, Davila CD, Romero-Corral A, Yun J, Pressman GS, Figueredo VM. Infective endocarditis epidemiology over five decades: a systematic review. PLoS One. 2013;8: e82665.
pubmed: 24349331
pmcid: 3857279
doi: 10.1371/journal.pone.0082665
Mangner N, Woitek F, Haussig S, Schlotter F, Stachel G, Höllriegel R, Wilde J, Lindner A, Holzhey D, Leontyev S, Mohr FW, Schuler G, Linke A. Incidence, predictors, and outcome of patients developing infective endocarditis following transfemoral transcatheter aortic valve replacement. J Am Coll Cardiol. 2016;67:2907–8.
pubmed: 27311532
doi: 10.1016/j.jacc.2016.03.588
Van Dijck I, Budts W, Cools B, Eyskens B, Boshoff DE, Heying R, Frerich S, Vanagt WY, Troost E, Gewillig M. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart. 2015;101:788–93.
pubmed: 25539944
doi: 10.1136/heartjnl-2014-306761
Bjursten H, Rasmussen M, Nozohoor S, Götberg M, Olaison L, Rück A, Ragnarsson S. Infective endocarditis after transcatheter aortic valve implantation: a nationwide study. Eur Heart J. 2019;40:3263–9.
pubmed: 31433472
pmcid: 6911164
doi: 10.1093/eurheartj/ehz588
Menchi-Elanzi M, Ramos-Rincón JM, Merino-Lucas E, Reus-Bañuls S, Torrús-Tendero D, Clíment-Paya V, Boix V, Portilla-Sogorb J. Infective endocarditis in elderly and very elderly patients. Aging Clin Exp Res. 2020;32:1383–8.
pubmed: 31429005
doi: 10.1007/s40520-019-01314-3
Wu Z, Chen Y, Xiao T, Niu T, Shi Q, Xiao Y. Epidemiology and risk factors of infective endocarditis in a tertiary hospital in China from 2007 to 2016. BMC Infect Dis. 2020;20:428.
pubmed: 32552765
pmcid: 7301995
doi: 10.1186/s12879-020-05153-w
Wang A, Gaca JG, Chu VH. Management considerations in infective endocarditis: a review. JAMA. 2018;320:72–83.
pubmed: 29971402
doi: 10.1001/jama.2018.7596
Bayliss R, Clarke C, Oakley CM, Somerville W, Whitfield AG, Young SE. The microbiology and pathogenesis of infective endocarditis. Br Heart J. 1983;50:513–9.
pubmed: 6651993
pmcid: 481452
doi: 10.1136/hrt.50.6.513
Zaqout A, Mohammed S, Thapur M, Al-Soub H, Al-Maslamani MA, Al-Khal A, Omrani AS. Clinical characteristics, microbiology, and outcomes of infective endocarditis in Qatar. Qatar Med J. 2020;2020:24.
pubmed: 33282709
pmcid: 7684547
doi: 10.5339/qmj.2020.24
Wang A. Recent progress in the understanding of infective endocarditis. Curr Treat Options Cardiovasc Med. 2011;13:586–94.
pubmed: 21922184
doi: 10.1007/s11936-011-0146-5
Galar A, Weil AA, Dudzinski DM, Muñoz P, Siedner MJ. Methicillin-resistant Staphylococcus aureus prosthetic valve endocarditis: pathophysiology, epidemiology, clinical presentation, diagnosis, and management. Clin Microbiol Rev. 2019. https://doi.org/10.1128/CMR.00041-18 .
doi: 10.1128/CMR.00041-18
pubmed: 30760474
pmcid: 6431130
Hilbig A, Cheng A. Infective endocarditis in the intravenous drug use population at a tertiary hospital in Melbourne, Australia. Heart Lung Circ. 2020;29:246–53.
pubmed: 30962062
doi: 10.1016/j.hlc.2018.12.016
Hidalgo-Tenorio C, Gálvez J, Martínez-Marcos FJ, Plata-Ciezar A, De La Torre-Lima J, López-Cortés LE, Noureddine M, Reguera JM, Vinuesa D, García MV, Ojeda G, Luque R, Lomas JM, Lepe JA, de Alarcón A. Clinical and prognostic differences between methicillin-resistant and methicillin-susceptible Staphylococcus aureus infective endocarditis. BMC Infect Dis. 2020;20:160.
pubmed: 32085732
pmcid: 7035751
doi: 10.1186/s12879-020-4895-1
Joo EJ, Park DA, Kang CI, Chung DR, Song JH, Lee SM, Peck KR. Reevaluation of the impact of methicillin-resistance on outcomes in patients with Staphylococcus aureus bacteremia and endocarditis. Korean J Intern Med. 2019;34:1347–62.
pubmed: 29347812
doi: 10.3904/kjim.2017.098
Givens M, Gennuso K, Jovaag A, Van Dijk J. County health rankings key findings report. County Health Rankings and Roadmaps; 2019.
de Loizaga SR, Arthur L, Arya B, Beckman B, Belay W, Brokamp C, Hyun Choi N, Connolly S, Dasgupta S, Dibert T, Dryer MM, Gokanapudy Hahn LR, Greene EA, Kernizan D, Khalid O, Klein J, Kobayashi R, Lahiri S, Lorenzoni RP, Otero Luna A, Marshall J, Millette T, Moore L, Muhamed B, Murali M, Parikh K, Sanyahumbi A, Shakti D, Stein E, Shah S, Wilkins H, Windom M, Wirth S, Zimmerman M, Beck AF, Ollberding N, Sable C, Beaton A. Rheumatic heart disease in the United States: forgotten but not gone: results of a 10 year multicenter review. J Am Heart Assoc. 2021;10: e020992.
pubmed: 34348475
pmcid: 8475057
doi: 10.1161/JAHA.120.020992
Gonzalez MML, Rachel O, Jessica S, Chloe MS (2018) Billings-Burford, Diahann Bronx Opioid Epidemic needs assessment. Columbia University School of International and Public Affairs. 2018; Spring 2018 Capstone Research Report
New York State Opioid Annual Report (2020) New York State Department of Health 2020
Holland DJ, Simos PA, Yoon J, Sivabalan P, Ramnarain J, Runnegar NJ. Infective endocarditis: a contemporary study of microbiology, echocardiography and associated clinical outcomes at a major tertiary referral centre. Heart Lung Circ. 2020;29:840–50.
pubmed: 31402124
doi: 10.1016/j.hlc.2019.07.006
O’Connor CT, O’Rourke S, Buckley A, Murphy R, Crean P, Foley B, Maree A, Ryan R, Tolan M, Young V, O’Connell B, Daly C. Infective endocarditis: a retrospective cohort study. QJM. 2019;112:663–7.
pubmed: 31147713
doi: 10.1093/qjmed/hcz134
Lu KJ, Kearney LG, Ord M, Jones E, Burrell LM, Srivastava PM. Age adjusted Charlson co-morbidity index is an independent predictor of mortality over long-term follow-up in infective endocarditis. Int J Cardiol. 2013;168:5243–8.
pubmed: 23978361
doi: 10.1016/j.ijcard.2013.08.023
Korem M, Israel S, Gilon D, Cahan A, Moses AE, Block C, Strahilevitz J. Epidemiology of infective endocarditis in a tertiary-center in Jerusalem: a 3-year prospective survey. Eur J Intern Med. 2014;25:550–5.
pubmed: 24931808
doi: 10.1016/j.ejim.2014.05.011
Jordal S, Kittang BR, Salminen PR, Eide GE, Kommedal Ø, Wendelbo Ø, Haaverstad R, Sjursen H. Infective endocarditis in Western Norway: a 20-year retrospective survey. Infect Dis (Lond). 2018;50:757–63.
pubmed: 29916753
doi: 10.1080/23744235.2018.1482419
Hase R, Otsuka Y, Yoshida K, Hosokawa N. Profile of infective endocarditis at a tertiary-care hospital in Japan over a 14-year period: characteristics, outcome and predictors for in-hospital mortality. Int J Infect Dis. 2015;33:62–6.
pubmed: 25576825
doi: 10.1016/j.ijid.2015.01.003
Cecchi E, Chirillo F, Castiglione A, Faggiano P, Cecconi M, Moreo A, Cialfi A, Rinaldi M, Del Ponte S, Squeri A, Corcione S, Canta F, Gaddi O, Enia F, Forno D, Costanzo P, Zuppiroli A, Ronzani G, Bologna F, Patrignani A, Belli R, Ciccone G, De Rosa FG. Clinical epidemiology in Italian registry of infective endocarditis (RIEI): focus on age, intravascular devices and enterococci. Int J Cardiol. 2015;190:151–6.
pubmed: 25918069
doi: 10.1016/j.ijcard.2015.04.123
Wang CY, Wang YC, Yang YS, Chang CY, Chen KY, Lai JJ, Lin JC, Chang FY. Microbiological features, clinical characteristics and outcomes of infective endocarditis in adults with and without hemodialysis: a 10-year retrospective study in Northern Taiwan. J Microbiol Immunol Infect. 2020;53:336–43.
pubmed: 30241988
doi: 10.1016/j.jmii.2018.08.013
Ma L, Ge Y, Ma H, Zhu B, Miao Q. Infective endocarditis at a tertiary-care hospital in China. J Cardiothorac Surg. 2020;15:135.
pubmed: 32522279
pmcid: 7285574
doi: 10.1186/s13019-020-01183-2
Zhu W, Zhang Q, Zhang J. The changing epidemiology and clinical features of infective endocarditis: a retrospective study of 196 episodes in a teaching hospital in China. BMC Cardiovasc Disord. 2017;17:113.
pubmed: 28482820
pmcid: 5422999
doi: 10.1186/s12872-017-0548-8
Babeș EE, Lucuța DA, Petcheși CD, Zaha AA, Ilyes C, Jurca AD, Vesa CM, Zaha DC, Babeș VV. Clinical features and outcome of infective endocarditis in a university hospital in Romania. Medicina (Kaunas). 2021;57:158.
pubmed: 33578787
doi: 10.3390/medicina57020158
Shahid U, Sharif H, Farooqi J, Jamil B, Khan E. Microbiological and clinical profile of infective endocarditis patients: an observational study experience from tertiary care center Karachi Pakistan. J Cardiothorac Surg. 2018;13:94.
pubmed: 30219083
pmcid: 6139130
doi: 10.1186/s13019-018-0781-y
Khan MZ, Khan MU, Syed M, Balla S. Trends in microbiology data and association with mortality in infective endocarditis (2002–2017). Am J Cardiol. 2021;142:155–6.
pubmed: 33387471
doi: 10.1016/j.amjcard.2020.12.055
Shah ASV, McAllister DA, Gallacher P, Astengo F, Rodríguez Pérez JA, Hall J, Lee KK, Bing R, Anand A, Nathwani D, Mills NL, Newby DE, Marwick C, Cruden NL. Incidence, microbiology, and outcomes in patients hospitalized with infective endocarditis. Circulation. 2020;141:2067–77.
pubmed: 32410460
pmcid: 7306256
doi: 10.1161/CIRCULATIONAHA.119.044913
Habib G, Erba PA, Iung B, Donal E, Cosyns B, Laroche C, Popescu BA, Prendergast B, Tornos P, Sadeghpour A, Oliver L, Vaskelyte JJ, Sow R, Axler O, Maggioni AP, Lancellotti P. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J. 2019;40:3222–32.
pubmed: 31504413
doi: 10.1093/eurheartj/ehz620
Sousa C, Botelho C, Rodrigues D, Azeredo J, Oliveira R. Infective endocarditis in intravenous drug abusers: an update. Eur J Clin Microbiol Infect Dis. 2012;31:2905–10.
pubmed: 22714640
doi: 10.1007/s10096-012-1675-x
Fowler VG Jr, Miro JM, Hoen B, Cabell CH, Abrutyn E, Rubinstein E, Corey GR, Spelman D, Bradley SF, Barsic B, Pappas PA, Anstrom KJ, Wray D, Fortes CQ, Anguera I, Athan E, Jones P, van der Meer JT, Elliott TS, Levine DP, Bayer AS. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005;293:3012–21.
pubmed: 15972563
doi: 10.1001/jama.293.24.3012
Kadri AN, Wilner B, Hernandez AV, Nakhoul G, Chahine J, Griffin B, Pettersson G, Grimm R, Navia J, Gordon S, Kapadia SR, Harb SC. Geographic trends, patient characteristics, and outcomes of infective endocarditis associated with drug abuse in the United States from 2002 to 2016. J Am Heart Assoc. 2019;8: e012969.
pubmed: 31530066
pmcid: 6806029
doi: 10.1161/JAHA.119.012969
Ahtela E, Oksi J, Sipilä J, Rautava P, Kytö V. Occurrence of fatal infective endocarditis: a population-based study in Finland. BMC Infect Dis. 2019;19:987.
pubmed: 31752727
pmcid: 6873758
doi: 10.1186/s12879-019-4620-0
Tzoumas A, Arfaras-Melainis A, Loufopoulos I, Vasiloulis T, Nagraj S, Liaqat W, Kokkinidis D, Palaiodimos L. Risk factors of all-cause mortality after surgically-treated infective endocarditis: a meta-analysis of hazard ratios. J Am Coll Cardiol. 2021;77:1774–1774.
doi: 10.1016/S0735-1097(21)03130-2
Lin CJ, Chua S, Chung SY, Hang CL, Tsai TH. Diabetes mellitus: an independent risk factor of in-hospital mortality in patients with infective endocarditis in a new era of clinical practice. Int J Environ Res Public Health. 2019;16:2248.
pubmed: 31242695
pmcid: 6617149
doi: 10.3390/ijerph16122248
Joffre J, Dumas G, Aegerter P, Dubée V, Bigé N, Preda G, Baudel JL, Maury E, Guidet B, Ait-Oufella H. Epidemiology of infective endocarditis in French intensive care units over the 1997–2014 period-from CUB-Réa network. Crit Care. 2019;23:143.
pubmed: 31027489
pmcid: 6485099
doi: 10.1186/s13054-019-2387-8
Agrawal A, Virk HUH, Riaz I, Jain D, Tripathi B, Krittanawong C, Bozorgnia B, Figueredo V, McCullough PA, Rangaswami J. Predictors of 30-day re-admissions in patients with infective endocarditis: a national population based cohort study. Rev Cardiovasc Med. 2020;21:123–7.
pubmed: 32259911
doi: 10.31083/j.rcm.2020.01.552
Lakhundi S, Zhang K. Methicillin-resistant Staphylococcus aureus: molecular characterization, evolution, and epidemiology. Clin Microbiol Rev. 2018. https://doi.org/10.1128/CMR.00020-18 .
doi: 10.1128/CMR.00020-18
pubmed: 30209034
pmcid: 6148192
David MZ, Daum RS. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 2010;23:616–87.
pubmed: 20610826
pmcid: 2901661
doi: 10.1128/CMR.00081-09
Fernández-Hidalgo N, Ribera A, Larrosa MN, Viedma E, Origüen J, de Alarcón A, Fariñas MC, Sáez C, Peña C, Múñez E, GarcíaLópez MV, Gavaldà J, Pérez-Montarelo D, Chaves F, Almirante B. Impact of Staphylococcus aureus phenotype and genotype on the clinical characteristics and outcome of infective endocarditis. A multicentre, longitudinal, prospective, observational study. Clin Microbiol Infect. 2018;24:985–91.
pubmed: 29269091
doi: 10.1016/j.cmi.2017.12.002
Nader N, Medina RI, Pescador L, Mantilla BM, Bravo JS, Gómez CH. Characterization of patients with bacteremia by methicillin-resistant Staphylococcus aureus in a high-complexity military hospital. Biomedica. 2019;39:86–95.
pubmed: 31529851
doi: 10.7705/biomedica.v39i2.4072
Bassetti M, Peghin M, Trecarichi EM, Carnelutti A, Righi E, Del Giacomo P, Ansaldi F, Trucchi C, Alicino C, Cauda R, Sartor A, Spanu T, Scarparo C, Tumbarello M. Characteristics of Staphylococcus aureus bacteraemia and predictors of early and late mortality. PLoS One. 2017;12: e0170236.
pubmed: 28152067
pmcid: 5289427
doi: 10.1371/journal.pone.0170236
Fukuta Y, Cunningham CA, Harris PL, Wagener MM, Muder RR. Identifying the risk factors for hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection among patients colonized with MRSA on admission. Infect Control Hosp Epidemiol. 2012;33:1219–25.
pubmed: 23143359
doi: 10.1086/668420
Wang JT, Liao CH, Fang CT, Chie WC, Lai MS, Lauderdale TL, Lee WS, Huang JH, Chang SC. Prevalence of and risk factors for colonization by methicillin-resistant Staphylococcus aureus among adults in community settings in Taiwan. J Clin Microbiol. 2009;47:2957–63.
pubmed: 19625471
pmcid: 2738089
doi: 10.1128/JCM.00853-09
Jernigan JA, Pullen AL, Partin C, Jarvis WR. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus in an outpatient clinic population. Infect Control Hosp Epidemiol. 2003;24:445–50.
pubmed: 12828323
doi: 10.1086/502223
Imahara SD, Friedrich JB. Community-acquired methicillin-resistant Staphylococcus aureus in surgically treated hand infections. J Hand Surg Am. 2010;35:97–103.
pubmed: 19962836
doi: 10.1016/j.jhsa.2009.09.004
Asgeirsson H, Thalme A, Weiland O. Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: experience from a Swedish referral hospital. Medicine (Baltimore). 2016;95: e5617.
pubmed: 27930590
doi: 10.1097/MD.0000000000005617
Pericàs JM, Llopis J, Athan E, Hernández-Meneses M, Hannan MM, Murdoch DR, Kanafani Z, Freiberger T, Strahilevitz J, Fernández-Hidalgo N, Lamas C, Durante-Mangoni E, Tattevin P, Nacinovich F, Chu VH, Miró JM. Prospective cohort study of infective endocarditis in people who inject drugs. J Am Coll Cardiol. 2021;77:544–55.
pubmed: 33538252
doi: 10.1016/j.jacc.2020.11.062
Goyal A, Mohan B, Kumar P, Gupta D, Tandon R, Singla S, Singh G, Singh B, Chhabra ST, Aslam N, Wander GS. Clinical characteristics and outcome of infective endocarditis among intravenous drug abusers in India. Indian Heart J. 2020;72:547–51.
pubmed: 33357643
pmcid: 7772606
doi: 10.1016/j.ihj.2020.09.014
Jones MR, Viswanath O, Peck J, Kaye AD, Gill JS, Simopoulos TT. A brief history of the opioid epidemic and strategies for pain medicine. Pain Ther. 2018;7:13–21.
pubmed: 29691801
pmcid: 5993682
doi: 10.1007/s40122-018-0097-6
Lyden J, Binswanger IA. The United States opioid epidemic. Semin Perinatol. 2019;43:123–31.
pubmed: 30711195
pmcid: 6578581
doi: 10.1053/j.semperi.2019.01.001
Rudasill SE, Sanaiha Y, Mardock AL, Khoury H, Xing H, Antonios JW, McKinnell JA, Benharash P. Clinical outcomes of infective endocarditis in injection drug users. J Am Coll Cardiol. 2019;73:559–70.
pubmed: 30732709
doi: 10.1016/j.jacc.2018.10.082
Siciliano RF, Gualandro DM, Bittencourt MS, Paixão M, Marcondes-Braga F, Soeiro AM, Strunz C, Pacanaro AP, Puelacher C, Tarasoutchi F, Di Somma S, Caramelli B, de Oliveira Junior MT, Mansur AJ, Mueller C, Barretto ACP, Strabelli TMV. Biomarkers for prediction of mortality in left-sided infective endocarditis. Int J Infect Dis. 2020;96:25–30.
pubmed: 32169690
doi: 10.1016/j.ijid.2020.03.009
Ferreira JP, Gomes F, Rodrigues P, Araújo Abreu M, Maia JM, Bettencourt P, Luz A, Torres S, Araújo CJ. Left-sided infective endocarditis: analysis of in-hospital and medium-term outcome and predictors of mortality. Rev Port Cardiol. 2013;32:777–84.
pubmed: 24209740
doi: 10.1016/j.repc.2012.11.015
Sunder S, Grammatico-Guillon L, Lemaignen A, Lacasse M, Gaborit C, Boutoille D, Tattevin P, Denes E, Guimard T, Dupont M, Fauchier L, Bernard L. Incidence, characteristics, and mortality of infective endocarditis in France in 2011. PLoS One. 2019;14: e0223857.
pubmed: 31652280
pmcid: 6814232
doi: 10.1371/journal.pone.0223857
Guiomar N, Vaz-da-Silva M, Mbala D, Sousa-Pinto B, Monteiro JP, Ponce P, Carneiro F, Guerra M, Neves F, Ferraz R, Rijo D, Teixeira M, Vouga L, Braga P. Cardiac surgery in infective endocarditis and predictors of in-hospital mortality. Rev Port Cardiol (Engl Ed). 2020;39:137–49.
pubmed: 32340853
doi: 10.1016/j.repc.2019.08.009
Hartman L, Barnes E, Bachmann L, Schafer K, Lovato J, Files DC. Opiate injection-associated infective endocarditis in the Southeastern United States. Am J Med Sci. 2016;352:603–8.
pubmed: 27916215
pmcid: 5830130
doi: 10.1016/j.amjms.2016.08.010
Kim JB, Ejiofor JI, Yammine M, Ando M, Camuso JM, Youngster I, Nelson SB, Kim AY, Melnitchouk SI, Rawn JD, MacGillivray TE, Cohn LH, Byrne JG, Sundt TM 3rd. Surgical outcomes of infective endocarditis among intravenous drug users. J Thorac Cardiovasc Surg. 2016;152:832-841.e1.
pubmed: 27068439
doi: 10.1016/j.jtcvs.2016.02.072